Heparan Sulfate Proteoglycan Binding Properties of Adeno-Associated Virus Retargeting Mutants and Consequences for Their In Vivo Tropism
Open Access
- 15 July 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (14) , 7265-7269
- https://doi.org/10.1128/jvi.00076-06
Abstract
Adeno-associated virus type 2 (AAV-2) targeting vectors have been generated by insertion of ligand peptides into the viral capsid at amino acid position 587. This procedure ablates binding of heparan sulfate proteoglycan (HSPG), AAV-2's primary receptor, in some but not all mutants. Using an AAV-2 display library, we investigated molecular mechanisms responsible for this phenotype, demonstrating that peptides containing a net negative charge are prone to confer an HSPG nonbinding phenotype. Interestingly, in vivo studies correlated the inability to bind to HSPG with liver and spleen detargeting in mice after systemic application, suggesting several strategies to improve efficiency of AAV-2 retargeting to alternative tissues.Keywords
This publication has 14 references indexed in Scilit:
- Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated virusesMolecular Therapy, 2006
- Combinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virusThe Journal of Gene Medicine, 2005
- Targeted Gene Delivery to Vascular Tissue In Vivo by Tropism-Modified Adeno-Associated Virus VectorsCirculation, 2004
- Development of Efficient Viral Vectors Selective for Vascular Smooth Muscle CellsMolecular Therapy, 2004
- Identification of a Heparin-Binding Motif on Adeno-Associated Virus Type 2 CapsidsJournal of Virology, 2003
- In vitro selection of viral vectors with modified tropism: the adeno-associated virus displayMolecular Therapy, 2003
- Receptor targeting of adeno-associated virus vectorsGene Therapy, 2003
- Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface ReceptorsJournal of Virology, 2002
- Efficient and Selective AAV2-Mediated Gene Transfer Directed to Human Vascular Endothelial CellsMolecular Therapy, 2001
- Incorporation of Tumor-Targeting Peptides into Recombinant Adeno-associated Virus CapsidsMolecular Therapy, 2001